COMMUNIQUÉS West-GlobeNewswire

-
Protara Therapeutics to Participate in Upcoming Investor Conferences
13/05/2025 -
Werewolf Therapeutics to Participate in Hanson Wade’s 6th Annual Cytokine-Based Drug Development Summit
13/05/2025 -
Remedy Plan Therapeutics Raises $18 Million Financing to Accelerate Advancement of Lead Asset RPT1G into Phase 1/2 Trials
13/05/2025 -
CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates
13/05/2025 -
Apyx Medical Corporation Receives FDA Clearance for the AYON Body Contouring System™
13/05/2025 -
ALX Oncology to Host R&D Webcast Event Highlighting its Novel EGFR Targeting Antibody-Drug Conjugate, ALX2004, on May 20, 2025
13/05/2025 -
Reflect Scientific Secures Patents for Data Center Cooling with Cryogenic Innovation
13/05/2025 -
EnteroBiotix Presents Positive Data in Liver Cirrhosis at EASL 2025
13/05/2025 -
Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor
13/05/2025 -
SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury
13/05/2025 -
Candel Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
13/05/2025 -
VivoSim’s NAMKind™ Intestine Wins Blue Ribbon Award at Digestive Disease Week Conference
13/05/2025 -
Affimed Announces Filing for the Opening of Insolvency Proceedings
13/05/2025 -
OneMedNet Enhances Data Discovery and Analytics with the Datavant Connect platform and Amazon Web Service (AWS) Clean Rooms
13/05/2025 -
Nexalin Technology Reconstitutes Scientific Advisory Board with Leading Experts to Advance Alzheimer’s Program Amid Encouraging Data
13/05/2025 -
Bright Minds Biosciences Announces Positive Findings from its DBA/2 Mouse Model Study Evaluating BMB-101
13/05/2025 -
Intelligent Bio Solutions Announces Fiscal Q3 2025 Financial Results and Key Operational Achievements
13/05/2025 -
Oragenics, Inc. Announces Approval to Initiate Phase II Concussion Drug Trial in Australia
13/05/2025 -
Tenaya Therapeutics to Highlight Capsid Engineering, Gene Editing and Manufacturing Research at the ASGCT 28th Annual Meeting
13/05/2025
Pages